| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30014605 | HIV | ENSG00000174175.17 | protein_coding | SELP | No | No | 6403 | P16109 Q5R341 Q6NUL9 |
| TVIS20029044 | HPV | ENSG00000174175.17 | protein_coding | SELP | No | No | 6403 | P16109 Q5R341 Q6NUL9 |
| TVIS20048087 | HPV | ENSG00000174175.17 | protein_coding | SELP | No | No | 6403 | P16109 Q5R341 Q6NUL9 |
| TVIS20068815 | HPV | ENSG00000174175.17 | protein_coding | SELP | No | No | 6403 | P16109 Q5R341 Q6NUL9 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SELP |
|---|---|
| DrugBank ID | DB08813 |
| Drug Name | Nadroparin |
| Target ID | BE0001159 |
| UniProt ID | P16109 |
| Regulation Type | inhibitor |
| PubMed IDs | 17629851; 16525583 |
| Citations | Simonis D, Christ K, Alban S, Bendas G: Affinity and kinetics of different heparins binding to P- and L-selectin. Semin Thromb Hemost. 2007 Jul;33(5):534-9.@@Ludwig RJ, Alban S, Bistrian R, Boehncke WH, Kaufmann R, Henschler R, Gille J: The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo. Thromb Haemost. 2006 Mar;95(3):535-40. |
| Groups | Approved; Investigational |
| Direct Classification | |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |